38 related articles for article (PubMed ID: 24732354)
1. The structure of the ternary Eg5-ADP-ispinesib complex.
Talapatra SK; Schüttelkopf AW; Kozielski F
Acta Crystallogr D Biol Crystallogr; 2012 Oct; 68(Pt 10):1311-9. PubMed ID: 22993085
[TBL] [Abstract][Full Text] [Related]
2. Binding patterns of inhibitors to different pockets of kinesin Eg5.
Jia N; Zhang B; Huo Z; Qin J; Ji Q; Geng Y
Arch Biochem Biophys; 2024 Jun; 756():109998. PubMed ID: 38641233
[TBL] [Abstract][Full Text] [Related]
3. The crystal structure and biochemical characterization of Kif15: a bifunctional molecular motor involved in bipolar spindle formation and neuronal development.
Klejnot M; Falnikar A; Ulaganathan V; Cross RA; Baas PW; Kozielski F
Acta Crystallogr D Biol Crystallogr; 2014 Jan; 70(Pt 1):123-33. PubMed ID: 24419385
[TBL] [Abstract][Full Text] [Related]
4. KIF15 nanomechanics and kinesin inhibitors, with implications for cancer chemotherapeutics.
Milic B; Chakraborty A; Han K; Bassik MC; Block SM
Proc Natl Acad Sci U S A; 2018 May; 115(20):E4613-E4622. PubMed ID: 29703754
[TBL] [Abstract][Full Text] [Related]
5. Real-time structural transitions are coupled to chemical steps in ATP hydrolysis by Eg5 kinesin.
Jun B; Kim S
J Biol Chem; 2010 Apr; 285(15):11073-7. PubMed ID: 20154092
[TBL] [Abstract][Full Text] [Related]
6. Identifying and characterising promising small molecule inhibitors of kinesin spindle protein using ligand-based virtual screening, molecular docking, molecular dynamics and MM‑GBSA calculations.
Elseginy SA
J Comput Aided Mol Des; 2024 Apr; 38(1):16. PubMed ID: 38556596
[TBL] [Abstract][Full Text] [Related]
7. Eg5 and Diseases: From the Well-Known Role in Cancer to the Less-Known Activity in Noncancerous Pathological Conditions.
Ricci A; Carradori S; Cataldi A; Zara S
Biochem Res Int; 2024; 2024():3649912. PubMed ID: 38939361
[TBL] [Abstract][Full Text] [Related]
8. Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors.
Chattopadhyay S; Stewart AL; Mukherjee S; Huang C; Hartwell KA; Miller PG; Subramanian R; Carmody LC; Yusuf RZ; Sykes DB; Paulk J; Vetere A; Vallet S; Santo L; Cirstea DD; Hideshima T; Dančík V; Majireck MM; Hussain MM; Singh S; Quiroz R; Iaconelli J; Karmacharya R; Tolliday NJ; Clemons PA; Moore MAS; Stern AM; Shamji AF; Ebert BL; Golub TR; Raje NS; Scadden DT; Schreiber SL
Cell Rep; 2015 Feb; 10(5):755-770. PubMed ID: 25660025
[TBL] [Abstract][Full Text] [Related]
9. Spindle assembly checkpoint protein expression correlates with cellular proliferation and shorter time to recurrence in ovarian cancer.
McGrogan B; Phelan S; Fitzpatrick P; Maguire A; Prencipe M; Brennan D; Doyle E; O'Grady A; Kay E; Furlong F; McCann A
Hum Pathol; 2014 Jul; 45(7):1509-19. PubMed ID: 24792619
[TBL] [Abstract][Full Text] [Related]
10. Kinesin-5 Eg5 is essential for spindle assembly, chromosome stability and organogenesis in development.
Yu WX; Li YK; Xu MF; Xu CJ; Chen J; Wei YL; She ZY
Cell Death Discov; 2022 Dec; 8(1):490. PubMed ID: 36513626
[TBL] [Abstract][Full Text] [Related]
11. Kinesin-5 Eg5 is essential for spindle assembly and chromosome alignment of mouse spermatocytes.
She ZY; Zhong N; Yu KW; Xiao Y; Wei YL; Lin Y; Li YL; Lu MH
Cell Div; 2020; 15():6. PubMed ID: 32165913
[TBL] [Abstract][Full Text] [Related]
12. Kinesin family member 11 contributes to the progression and prognosis of human breast cancer.
Pei YY; Li GC; Ran J; Wei FX
Oncol Lett; 2017 Dec; 14(6):6618-6626. PubMed ID: 29181100
[TBL] [Abstract][Full Text] [Related]
13. Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of mitotic kinesin Eg5.
Sun XD; Shi XJ; Sun XO; Luo YG; Wu XJ; Yao CF; Yu HY; Li DW; Liu M; Zhou J
Acta Pharmacol Sin; 2011 Dec; 32(12):1543-8. PubMed ID: 21986572
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for inhibition of Eg5 by dihydropyrimidines: stereoselectivity of antimitotic inhibitors enastron, dimethylenastron and fluorastrol.
Kaan HY; Ulaganathan V; Rath O; Prokopcová H; Dallinger D; Kappe CO; Kozielski F
J Med Chem; 2010 Aug; 53(15):5676-83. PubMed ID: 20597485
[TBL] [Abstract][Full Text] [Related]
15. STLC-resistant cell lines as tools to classify chemically divergent Eg5 targeting agents according to their mode of action and target specificity.
Indorato RL; DeBonis S; Kozielski F; Garcia-Saez I; Skoufias DA
Biochem Pharmacol; 2013 Nov; 86(10):1441-51. PubMed ID: 24041742
[TBL] [Abstract][Full Text] [Related]
16. Progress on kinesin spindle protein inhibitors as anti-cancer agents.
Zhang Y; Xu W
Anticancer Agents Med Chem; 2008 Aug; 8(6):698-704. PubMed ID: 18690830
[TBL] [Abstract][Full Text] [Related]
17. Eg5 targeting agents: From new anti-mitotic based inhibitor discovery to cancer therapy and resistance.
Garcia-Saez I; Skoufias DA
Biochem Pharmacol; 2021 Feb; 184():114364. PubMed ID: 33310050
[TBL] [Abstract][Full Text] [Related]
18. Significant decrease of ADP release rate underlies the potent activity of dimethylenastron to inhibit mitotic kinesin Eg5 and cancer cell proliferation.
Sun L; Sun X; Xie S; Yu H; Zhong D
Biochem Biophys Res Commun; 2014 May; 447(3):465-70. PubMed ID: 24732354
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
